Celldex Therapeutics to Present at Upcoming Investor Conferences
Celldex Therapeutics (NASDAQ:CLDX) has announced its upcoming participation in two major investor conferences in March 2025. The company's management will engage in fireside chat presentations at:
- The TD Cowen 45th Annual Health Care Conference on March 4th at 1:50 p.m. ET
- The Leerink Partners Global Healthcare Conference on March 11th at 1:00 p.m. ET
Both presentations will be accessible through live webcasts on the Celldex website's 'Events & Presentations' page under the 'Investors & Media' section. Replay access will remain available for 90 days after each event.
Celldex Therapeutics (NASDAQ:CLDX) ha annunciato la sua prossima partecipazione a due importanti conferenze per investitori a marzo 2025. La direzione dell'azienda parteciperà a presentazioni in formato fireside chat presso:
- La TD Cowen 45a Conferenza Annuale sulla Salute il 4 marzo alle 13:50 ET
- La Conferenza Globale sulla Salute di Leerink Partners l'11 marzo alle 13:00 ET
Entrambe le presentazioni saranno accessibili tramite webcast dal vivo sulla pagina 'Eventi e Presentazioni' del sito web di Celldex, nella sezione 'Investitori e Media'. L'accesso alla registrazione rimarrà disponibile per 90 giorni dopo ciascun evento.
Celldex Therapeutics (NASDAQ:CLDX) ha anunciado su próxima participación en dos importantes conferencias para inversores en marzo de 2025. La dirección de la empresa participará en presentaciones en formato fireside chat en:
- La 45ª Conferencia Anual de Salud de TD Cowen el 4 de marzo a la 1:50 p.m. ET
- La Conferencia Global de Salud de Leerink Partners el 11 de marzo a la 1:00 p.m. ET
Ambas presentaciones estarán disponibles a través de transmisiones en vivo en la página de 'Eventos y Presentaciones' del sitio web de Celldex, en la sección de 'Inversores y Medios'. El acceso a la repetición estará disponible durante 90 días después de cada evento.
셀덱스 테라퓨틱스 (NASDAQ:CLDX)는 2025년 3월에 두 개의 주요 투자자 회의에 참여할 예정이라고 발표했습니다. 회사 경영진은 다음과 같은 자리에서 화상 대담 형식의 발표를 진행할 것입니다:
- TD Cowen 제45회 연례 건강 관리 회의가 3월 4일 오후 1시 50분 ET에 진행됩니다.
- 리어링크 파트너스 글로벌 헬스케어 회의가 3월 11일 오후 1시 00분 ET에 진행됩니다.
두 발표 모두 셀덱스 웹사이트의 '이벤트 및 발표' 페이지의 '투자자 및 미디어' 섹션을 통해 실시간 웹캐스트로 접속할 수 있습니다. 각 이벤트 후 90일 동안 재생 접근이 가능합니다.
Celldex Therapeutics (NASDAQ:CLDX) a annoncé sa prochaine participation à deux grandes conférences pour investisseurs en mars 2025. La direction de l'entreprise participera à des présentations sous forme de fireside chat lors de :
- La 45ème Conférence Annuelle sur la Santé de TD Cowen le 4 mars à 13h50 ET
- La Conférence Mondiale sur la Santé de Leerink Partners le 11 mars à 13h00 ET
Les deux présentations seront accessibles via des webcasts en direct sur la page 'Événements et Présentations' du site Web de Celldex, dans la section 'Investisseurs et Médias'. L'accès à la rediffusion restera disponible pendant 90 jours après chaque événement.
Celldex Therapeutics (NASDAQ:CLDX) hat seine bevorstehende Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt. Das Management des Unternehmens wird an Fireside-Chat-Präsentationen teilnehmen bei:
- Der 45. jährlichen Gesundheitskonferenz von TD Cowen am 4. März um 13:50 Uhr ET
- Der Global Healthcare Conference von Leerink Partners am 11. März um 13:00 Uhr ET
Beide Präsentationen sind über Live-Webcasts auf der 'Events & Presentations'-Seite der Celldex-Website im Bereich 'Investoren & Medien' zugänglich. Der Zugriff auf die Wiederholung bleibt 90 Tage nach jeder Veranstaltung verfügbar.
- None.
- None.
HAMPTON, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:
TD Cowen 45th Annual Health Care Conference on Tuesday, March 4th at 1:50 p.m. ET
Leerink Partners Global Healthcare Conference on Tuesday, March 11th at 1:00 p.m. ET
Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
FAQ
When is Celldex (CLDX) presenting at the TD Cowen Healthcare Conference in March 2025?
What time is CLDX's presentation at the Leerink Partners Conference in March 2025?
How long will the CLDX conference presentation replays be available?
Where can investors watch Celldex's (CLDX) March 2025 conference presentations?
